Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 726

1.

Identification of Hip BMD Loss and Fracture Risk Markers Through Population-Based Serum Proteomics.

Nielson CM, Wiedrick J, Shen J, Jacobs J, Baker ES, Baraff A, Piehowski P, Lee CG, Baratt A, Petyuk V, McWeeney S, Lim JY, Bauer DC, Lane NE, Cawthon PM, Smith RD, Lapidus J, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Study Research Group..

J Bone Miner Res. 2017 Mar 18. doi: 10.1002/jbmr.3125. [Epub ahead of print]

PMID:
28316103
2.

Osteoporosis Treatment Efficacy for Men: A Systematic Review and Meta-Analysis.

Nayak S, Greenspan SL.

J Am Geriatr Soc. 2017 Mar;65(3):490-495. doi: 10.1111/jgs.14668. Epub 2016 Nov 7.

PMID:
28304090
3.

Time to Clinically Relevant Fracture Risk Scores in Postmenopausal Women.

Gourlay ML, Overman RA, Fine JP, Crandall CJ, Robbins J, Schousboe JT, Ensrud KE, LeBlanc ES, Gass ML, Johnson KC, Womack CR, LaCroix AZ; Women's Health Initiative Investigators..

Am J Med. 2017 Mar 9. pii: S0002-9343(17)30218-8. doi: 10.1016/j.amjmed.2017.02.012. [Epub ahead of print]

PMID:
28285070
4.

Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment.

Anastasilakis AD, Yavropoulou MP, Makras P, Sakellariou GT, Papadopoulou F, Gerou S, Papapoulos SE.

Eur J Endocrinol. 2017 Jun;176(6):677-683. doi: 10.1530/EJE-16-1027. Epub 2017 Mar 10.

PMID:
28283537
5.

Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study.

Kim SH, Joung JY, Kim S, Rha KH, Kim HG, Kwak C, Lee JY, Jeon SS, Hong SK, Jeong H, Jo MK, You D, Jeong IG, Hong JH, Kim CS.

Sci Rep. 2017 Mar 6;7:39562. doi: 10.1038/srep39562.

6.

The relationship between vitamin D receptor (VDR) polymorphism and the occurrence of osteoporosis in menopausal Iranian women.

Dabirnia R, Mahmazi S, Taromchi A, Nikzad M, Saburi E.

Clin Cases Miner Bone Metab. 2016 Sep-Dec;13(3):190-194. doi: 10.11138/ccmbm/2016.13.3.190. Epub 2017 Feb 10.

7.

Vertebral bone marrow fat, bone mineral density and diabetes: The Osteoporotic Fractures in Men (MrOS) study.

Sheu Y, Amati F, Schwartz AV, Danielson ME, Li X, Boudreau R, Cauley JA; Osteoporotic Fractures in Men (MrOS) Research Group..

Bone. 2017 Apr;97:299-305. doi: 10.1016/j.bone.2017.02.001. Epub 2017 Feb 4.

PMID:
28179169
8.

What Role Does Low Bone Mineral Density Play in the "Killer Turn" Effect after Transtibial Posterior Cruciate Ligament Reconstruction?

Li Y, Chen XZ, Zhang J, Song GY, Li X, Feng H.

Orthop Surg. 2016 Nov;8(4):483-489. doi: 10.1111/os.12284.

PMID:
28032708
9.

Treatment and Management of Osteoporotic Fractures: A Nation-wide Survey of 484 Senior Orthopaedists in China.

Man Y, Pan W, Lu J, Li SY, Zhang P, Guo JZ, Yu SF, Zhang B, Xiao E, Zhang C, Zuo W, Jin HJ, Chen Y, Wu B, Shi XE, Hong D, Liu X, Gao YX, Li J, Yin L, Xue QY.

Orthop Surg. 2016 Nov;8(4):432-439. doi: 10.1111/os.12296.

PMID:
28032704
10.

Own the Bone, a System-Based Intervention, Improves Osteoporosis Care After Fragility Fractures.

Bunta AD, Edwards BJ, Macaulay WB Jr, Jeray KJ, Tosi LL, Jones CB, Sietsema DL, Kaufman JD, Murphy SA, Song J, Goulet JA, Friedlaender GE, Swiontkowski MF, Dirschl DR.

J Bone Joint Surg Am. 2016 Dec 21;98(24):e109. doi: 10.2106/JBJS.15.01494.

PMID:
28002377
11.

Alendronate does not prevent long bone fragility in an inactive rat model.

Naruse K, Uchida K, Suto M, Miyagawa K, Kawata A, Urabe K, Takaso M, Itoman M, Mikuni-Takagaki Y.

J Bone Miner Metab. 2016 Nov;34(6):615-626. Epub 2015 Oct 16.

PMID:
26475371
12.

Celiac disease is associated with reduced bone mineral density and increased FRAX scores in the US National Health and Nutrition Examination Survey.

Kamycheva E, Goto T, Camargo CA Jr.

Osteoporos Int. 2017 Mar;28(3):781-790. doi: 10.1007/s00198-016-3791-4. Epub 2016 Oct 6.

PMID:
27714440
13.

Application of calcium phosphates and fibronectin as complementary treatment for osteoporotic bone fractures.

Plaza JQ, Garzón LB, Gimenez BB, Moraleda BF, Collía F, Rodríguez-Lorenzo LM.

Injury. 2016 Sep;47 Suppl 3:S15-S21. doi: 10.1016/S0020-1383(16)30601-5.

PMID:
27692101
14.

Biomechanical Analysis of Stability of Posterior Antiglide Plating in Osteoporotic Pronation Abduction Ankle Fracture Model With Posterior Tibial Fragment.

Hartwich K, Lorente Gomez A, Pyrc J, Gut R, Rammelt S, Grass R.

Foot Ankle Int. 2017 Jan;38(1):58-65. doi: 10.1177/1071100716669359. Epub 2016 Sep 30.

PMID:
27672062
15.

Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women.

Bilek LD, Waltman NL, Lappe JM, Kupzyk KA, Mack LR, Cullen DM, Berg K, Langel M, Meisinger M, Portelli-Trinidad A, Lang M.

BMC Womens Health. 2016 Aug 30;16(1):59. doi: 10.1186/s12905-016-0339-x.

16.

Framing moving and handling as a complex healthcare intervention within the acute care of older people with osteoporosis: a qualitative study.

Smith MC, O'May F, Tropea S, Berg J.

J Clin Nurs. 2016 Oct;25(19-20):2906-20. doi: 10.1111/jocn.13344. Epub 2016 Aug 22.

PMID:
27550628
17.

Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial.

Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, Alexandersen P, Zerbini CA, Hu MY, Harris AG, Fitzpatrick LA, Cosman F, Christiansen C; ACTIVE Study Investigators..

JAMA. 2016 Aug 16;316(7):722-33. doi: 10.1001/jama.2016.11136. Erratum in: JAMA. 2017 Jan 24;317(4):442.

PMID:
27533157
18.

Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.

Hansen L, Petersen KD, Eriksen SA, Gerstoft F, Vestergaard P.

Osteoporos Int. 2017 Jan;28(1):321-328. doi: 10.1007/s00198-016-3720-6. Epub 2016 Jul 30.

PMID:
27475930
19.

Osteoporosis diagnostics in patients with rheumatoid arthritis.

Węgierska M, Dura M, Blumfield E, Żuchowski P, Waszczak M, Jeka S.

Reumatologia. 2016;54(1):29-34. doi: 10.5114/reum.2016.58759. Epub 2016 Mar 24. Review.

20.

Inflammatory Markers and the Risk of Hip and Vertebral Fractures in Men: the Osteoporotic Fractures in Men (MrOS).

Cauley JA, Barbour KE, Harrison SL, Cloonan YK, Danielson ME, Ensrud KE, Fink HA, Orwoll ES, Boudreau R.

J Bone Miner Res. 2016 Dec;31(12):2129-2138. doi: 10.1002/jbmr.2905. Epub 2016 Jul 25.

PMID:
27371811

Supplemental Content

Loading ...
Support Center